69 articles, transcripts, and reports
Eli Lilly and Company (NYSE: LLY) announced that the results from its latest study indicated that its monoclonal antibody bamlanivimab reduced the risk of contracting…
Shares of Eli Lilly & Co. (NYSE: LLY) were up over 2% on Wednesday. The stock has gained over 30% since the beginning of this…
Eli Lilly and Company (NYSE : LLY) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Kevin Hern — Vice President, Investor Relations David A. Ricks — Chairman…
Eli Lilly & Co. (NYSE: LLY) Q2 2020 earnings call dated July 30, 2020 Presentation: Operator Ladies and gentlemen, thank you for standing by, and…
Eli Lilly & Co.’s (NYSE: LLY) shares have gained 29% since the beginning of the year and 16% over the past three months. The sentiment…
Eli Lilly & Co (LLY) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Kevin Hern — Vice President, Investor Relations David A. Ricks — Chairman and Chief…
Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year. Amid COVID-19 pandemic, the company saw increased customer…
Eli Lilly & Co (NYSE: LLY) Q4 2019 Earnings Conference Call January 30, 2020 Corporate Participants: Kevin Hern — Vice President of Investor Relations David A. Ricks — Chairman and…
— Eli Lilly and Company (NYSE: LLY) reported its fourth-quarter 2019 adjusted earnings of $1.73 per share versus $1.52 per share expected. — Revenue increased…
